Funtleyder Leslie D.
Insider CIK 1775394 · APLT See Remarks, Director · RVPH Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| APLT Applied Therapeutics, Inc. | D To issuer deriv | 2026-02-03 | 2026-02-03 | 20,460 | — | $0 | 0 | SEC↗ |
| APLT Applied Therapeutics, Inc. | D To issuer deriv | 2026-02-03 | 2026-02-03 | 16,500 | — | $0 | 0 | SEC↗ |
| APLT Applied Therapeutics, Inc. | D To issuer deriv | 2026-02-03 | 2026-02-03 | 16,500 | — | $0 | 0 | SEC↗ |
| APLT Applied Therapeutics, Inc. | D To issuer deriv | 2026-02-03 | 2026-02-03 | 150,000 | — | $0 | 0 | SEC↗ |
| APLT Applied Therapeutics, Inc. | D To issuer deriv | 2026-02-03 | 2026-02-03 | 40,502 | — | $0 | 0 | SEC↗ |
| APLT Applied Therapeutics, Inc. | D To issuer deriv | 2026-02-03 | 2026-02-03 | 10,230 | — | $0 | 0 | SEC↗ |
| APLT Applied Therapeutics, Inc. | U Tender | 2026-02-03 | 2026-02-03 | 152,959 | — | $0 | 0 | SEC↗ |
| APLT Applied Therapeutics, Inc. | D To issuer | 2026-02-03 | 2026-02-03 | 2,375,000 | — | $0 | 152,959 | SEC↗ |
| APLT Applied Therapeutics, Inc. | A Award | 2026-01-01 | 2026-01-02 | 150,000 | — | $0 | 1,340,459 | SEC↗ |
| APLT Applied Therapeutics, Inc. | A Award | 2025-12-19 | 2026-02-03 | 1,187,500 | — | $0 | 2,527,959 | SEC↗ |
| RVPH REVIVA PHARMACEUTICALS HOL | A Award deriv | 2025-12-18 | 2025-12-19 | 8,200 | — | $0 | 8,200 | SEC↗ |
| APLT Applied Therapeutics, Inc. | A Award | 2025-10-01 | 2025-10-01 | 150,000 | — | $0 | 1,190,459 | SEC↗ |
| APLT Applied Therapeutics, Inc. | A Award | 2025-07-01 | 2025-07-03 | 150,000 | — | $0 | 937,121 | SEC↗ |
| APLT Applied Therapeutics, Inc. | A Award | 2025-06-09 | 2025-07-03 | 150,000 | — | $0 | 787,121 | SEC↗ |
| APLT Applied Therapeutics, Inc. | A Award | 2025-03-24 | 2025-03-26 | 350,000 | — | $0 | 740,459 | SEC↗ |
| APLT Applied Therapeutics, Inc. | S Sale | 2025-03-04 | 2025-03-06 | 14,502 | $0.44 | $6.4K | 390,459 | SEC↗ |
| APLT Applied Therapeutics, Inc. | S Sale | 2025-02-06 | 2025-02-07 | 22,950 | $0.61 | $14.0K | 404,961 | SEC↗ |
| APLT Applied Therapeutics, Inc. | A Award deriv | 2024-12-19 | 2024-12-20 | 150,000 | — | $0 | 150,000 | SEC↗ |
| APLT Applied Therapeutics, Inc. | A Award | 2024-12-19 | 2024-12-20 | 150,000 | — | $0 | 427,911 | SEC↗ |
| RVPH REVIVA PHARMACEUTICALS HOL | A Award deriv | 2024-12-10 | 2024-12-12 | 8,200 | — | $0 | 8,200 | SEC↗ |
| APLT Applied Therapeutics, Inc. | S Sale | 2024-08-22 | 2024-08-23 | 13,530 | $5.83 | $78.9K | 277,911 | SEC↗ |
| APLT Applied Therapeutics, Inc. | S Sale | 2024-06-06 | 2024-06-10 | 16,980 | $4.32 | $73.4K | 291,441 | SEC↗ |
| APLT Applied Therapeutics, Inc. | S Sale | 2024-03-14 | 2024-03-18 | 28,727 | $5.39 | $154.8K | 308,421 | SEC↗ |
| APLT Applied Therapeutics Inc. | A Award | 2023-11-20 | 2023-11-20 | 300,000 | — | $0 | 337,148 | SEC↗ |
| RVPH REVIVA PHARMACEUTICALS HOL | A Award deriv | 2023-11-13 | 2023-11-14 | 8,200 | — | $0 | 8,200 | SEC↗ |
| APLT Applied Therapeutics Inc. | A Award | 2023-06-06 | 2023-06-08 | 20,000 | — | $0 | 37,148 | SEC↗ |
| RVPH REVIVA PHARMACEUTICALS HOL | A Award deriv | 2022-11-10 | 2022-11-14 | 3,900 | — | $0 | 3,900 | SEC↗ |
| APLT Applied Therapeutics Inc. | D To issuer deriv | 2022-08-02 | 2022-08-04 | 20,460 | — | $0 | 0 | SEC↗ |
| APLT Applied Therapeutics Inc. | D To issuer deriv | 2022-08-02 | 2022-08-04 | 16,500 | — | $0 | 0 | SEC↗ |
| APLT Applied Therapeutics Inc. | D To issuer deriv | 2022-08-02 | 2022-08-04 | 16,500 | — | $0 | 16,500 | SEC↗ |
| APLT Applied Therapeutics Inc. | D To issuer deriv | 2022-08-02 | 2022-08-04 | 16,500 | — | $0 | 0 | SEC↗ |
| APLT Applied Therapeutics Inc. | D To issuer deriv | 2022-08-02 | 2022-08-04 | 16,500 | — | $0 | 16,500 | SEC↗ |
| APLT Applied Therapeutics Inc. | D To issuer deriv | 2022-08-02 | 2022-08-04 | 10,230 | — | $0 | 0 | SEC↗ |
| APLT Applied Therapeutics Inc. | D To issuer deriv | 2022-08-02 | 2022-08-04 | 10,230 | — | $0 | 10,230 | SEC↗ |
| APLT Applied Therapeutics Inc. | D To issuer deriv | 2022-08-02 | 2022-08-04 | 20,460 | — | $0 | 20,460 | SEC↗ |
| APLT Applied Therapeutics Inc. | A Award deriv | 2022-06-03 | 2022-06-07 | 16,500 | — | $0 | 16,500 | SEC↗ |
| RVPH REVIVA PHARMACEUTICALS HOL | A Award deriv | 2021-12-08 | 2021-12-10 | 5,300 | — | $0 | 5,300 | SEC↗ |
| RVPH REVIVA PHARMACEUTICALS HOL | A Award deriv | 2021-06-15 | 2021-06-16 | 4,000 | — | $0 | 4,000 | SEC↗ |
| APLT Applied Therapeutics Inc. | A Award deriv | 2021-06-03 | 2021-06-04 | 16,500 | — | $0 | 16,500 | SEC↗ |
| APLT Applied Therapeutics Inc. | S Sale | 2020-10-02 | 2020-10-05 | 5,976 | $20.07 | $119.9K | 17,148 | SEC↗ |
| APLT Applied Therapeutics Inc. | M Exercise deriv | 2020-10-01 | 2020-10-05 | 30,000 | — | $0 | 40,502 | SEC↗ |
| APLT Applied Therapeutics Inc. | S Sale | 2020-10-01 | 2020-10-05 | 1,353 | $20.75 | $28.1K | 23,124 | SEC↗ |
| APLT Applied Therapeutics Inc. | M Exercise | 2020-10-01 | 2020-10-05 | 30,000 | $4.70 | $141.0K | 47,148 | SEC↗ |
| APLT Applied Therapeutics Inc. | S Sale | 2020-10-01 | 2020-10-05 | 22,671 | $20.03 | $454.1K | 24,477 | SEC↗ |
| APLT Applied Therapeutics Inc. | S Sale | 2020-08-24 | 2020-08-25 | 6,461 | $24.18 | $156.2K | 17,148 | SEC↗ |
| APLT Applied Therapeutics Inc. | S Sale | 2020-08-24 | 2020-08-25 | 13,539 | $23.42 | $317.1K | 23,609 | SEC↗ |
| APLT Applied Therapeutics Inc. | M Exercise deriv | 2020-08-21 | 2020-08-25 | 20,000 | — | $0 | 70,502 | SEC↗ |
| APLT Applied Therapeutics Inc. | M Exercise | 2020-08-21 | 2020-08-25 | 20,000 | $4.70 | $94.0K | 37,148 | SEC↗ |
| APLT Applied Therapeutics Inc. | S Sale | 2020-06-25 | 2020-06-25 | 200 | $36.12 | $7.2K | 17,765 | SEC↗ |
| APLT Applied Therapeutics Inc. | S Sale | 2020-06-25 | 2020-06-25 | 517 | $37.52 | $19.4K | 17,248 | SEC↗ |
| APLT Applied Therapeutics Inc. | S Sale | 2020-06-25 | 2020-06-25 | 100 | $38.28 | $3.8K | 17,148 | SEC↗ |
| APLT Applied Therapeutics Inc. | S Sale | 2020-06-24 | 2020-06-25 | 3,572 | $39.20 | $140.0K | 22,176 | SEC↗ |
| APLT Applied Therapeutics Inc. | S Sale | 2020-06-24 | 2020-06-25 | 3,811 | $40.41 | $154.0K | 18,365 | SEC↗ |
| APLT Applied Therapeutics Inc. | S Sale | 2020-06-24 | 2020-06-25 | 400 | $40.92 | $16.4K | 17,965 | SEC↗ |
| APLT Applied Therapeutics Inc. | S Sale | 2020-06-23 | 2020-06-25 | 3,462 | $44.54 | $154.2K | 29,057 | SEC↗ |
| APLT Applied Therapeutics Inc. | S Sale | 2020-06-23 | 2020-06-25 | 4,629 | $43.32 | $200.5K | 32,519 | SEC↗ |
| APLT Applied Therapeutics Inc. | S Sale | 2020-06-23 | 2020-06-25 | 1,809 | $45.35 | $82.0K | 27,248 | SEC↗ |
| APLT Applied Therapeutics Inc. | S Sale | 2020-06-23 | 2020-06-25 | 160 | $46.45 | $7.4K | 27,088 | SEC↗ |
| APLT Applied Therapeutics Inc. | S Sale | 2020-06-23 | 2020-06-25 | 1,340 | $47.40 | $63.5K | 25,748 | SEC↗ |
| APLT Applied Therapeutics Inc. | M Exercise deriv | 2020-06-22 | 2020-06-22 | 20,000 | — | $0 | 90,502 | SEC↗ |
| APLT Applied Therapeutics Inc. | M Exercise | 2020-06-22 | 2020-06-22 | 20,000 | $4.70 | $94.0K | 37,148 | SEC↗ |
| APLT Applied Therapeutics Inc. | S Sale | 2020-06-18 | 2020-06-22 | 11 | $45.90 | $505 | 17,148 | SEC↗ |
| APLT Applied Therapeutics Inc. | S Sale | 2020-06-18 | 2020-06-22 | 7,487 | $45.32 | $339.3K | 17,159 | SEC↗ |
| APLT Applied Therapeutics Inc. | S Sale | 2020-06-17 | 2020-06-17 | 4,100 | $44.15 | $181.0K | 24,646 | SEC↗ |
| APLT Applied Therapeutics Inc. | S Sale | 2020-06-16 | 2020-06-17 | 5,302 | $44.37 | $235.2K | 28,846 | SEC↗ |
| APLT Applied Therapeutics Inc. | S Sale | 2020-06-16 | 2020-06-17 | 100 | $45.18 | $4.5K | 28,746 | SEC↗ |
| APLT Applied Therapeutics Inc. | M Exercise deriv | 2020-06-15 | 2020-06-17 | 17,000 | — | $0 | 110,502 | SEC↗ |
| APLT Applied Therapeutics Inc. | M Exercise | 2020-06-15 | 2020-06-17 | 17,000 | $4.70 | $79.9K | 34,148 | SEC↗ |
| APLT Applied Therapeutics Inc. | S Sale | 2020-06-10 | 2020-06-10 | 2,563 | $42.83 | $109.8K | 17,148 | SEC↗ |
| APLT Applied Therapeutics Inc. | S Sale | 2020-06-10 | 2020-06-10 | 2,622 | $41.80 | $109.6K | 19,711 | SEC↗ |
| APLT Applied Therapeutics Inc. | S Sale | 2020-06-09 | 2020-06-10 | 1,500 | $44.87 | $67.3K | 22,333 | SEC↗ |
| APLT Applied Therapeutics Inc. | S Sale | 2020-06-09 | 2020-06-10 | 2,000 | $42.82 | $85.6K | 23,833 | SEC↗ |
| APLT Applied Therapeutics Inc. | M Exercise deriv | 2020-06-08 | 2020-06-10 | 17,000 | — | $0 | 127,502 | SEC↗ |
| APLT Applied Therapeutics Inc. | S Sale | 2020-06-08 | 2020-06-10 | 8,315 | $44.77 | $372.3K | 25,833 | SEC↗ |
| APLT Applied Therapeutics Inc. | M Exercise | 2020-06-08 | 2020-06-10 | 17,000 | $4.70 | $79.9K | 34,148 | SEC↗ |
| APLT Applied Therapeutics Inc. | A Award deriv | 2020-06-04 | 2020-06-04 | 10,230 | — | $0 | 10,230 | SEC↗ |
| APLT Applied Therapeutics Inc. | S Sale | 2020-06-04 | 2020-06-04 | 1,482 | $44.17 | $65.5K | 17,148 | SEC↗ |
| APLT Applied Therapeutics Inc. | S Sale | 2020-06-03 | 2020-06-04 | 1,032 | $44.03 | $45.4K | 18,630 | SEC↗ |
| APLT Applied Therapeutics Inc. | M Exercise deriv | 2020-06-02 | 2020-06-04 | 15,000 | — | $0 | 144,502 | SEC↗ |
| APLT Applied Therapeutics Inc. | S Sale | 2020-06-02 | 2020-06-04 | 12,486 | $45.21 | $564.5K | 19,662 | SEC↗ |
| APLT Applied Therapeutics Inc. | M Exercise | 2020-06-02 | 2020-06-04 | 15,000 | $4.70 | $70.5K | 32,148 | SEC↗ |
| APLT Applied Therapeutics Inc. | S Sale | 2020-05-29 | 2020-06-01 | 7,120 | $44.27 | $315.2K | 25,643 | SEC↗ |
| APLT Applied Therapeutics Inc. | S Sale | 2020-05-29 | 2020-06-01 | 8,495 | $45.08 | $383.0K | 17,148 | SEC↗ |
| APLT Applied Therapeutics Inc. | M Exercise deriv | 2020-05-28 | 2020-06-01 | 18,453 | — | $0 | 0 | SEC↗ |
| APLT Applied Therapeutics Inc. | S Sale | 2020-05-28 | 2020-06-01 | 2,838 | $48.27 | $137.0K | 32,763 | SEC↗ |
| APLT Applied Therapeutics Inc. | M Exercise | 2020-05-28 | 2020-06-01 | 18,453 | $0.04 | $738 | 35,601 | SEC↗ |
| APLT Applied Therapeutics Inc. | A Award deriv | 2019-06-03 | 2019-06-05 | 20,460 | — | $0 | 20,460 | SEC↗ |
| APLT Applied Therapeutics Inc. | C Conversion deriv | 2019-05-16 | 2019-05-20 | 1,325 | — | $0 | 0 | SEC↗ |
| APLT Applied Therapeutics Inc. | C Conversion deriv | 2019-05-16 | 2019-05-20 | 3,314 | — | $0 | 0 | SEC↗ |
| APLT Applied Therapeutics Inc. | C Conversion | 2019-05-16 | 2019-05-20 | 1,325 | — | $0 | 13,810 | SEC↗ |
| APLT Applied Therapeutics Inc. | C Conversion | 2019-05-16 | 2019-05-20 | 3,314 | — | $0 | 12,485 | SEC↗ |